Yahoo Finance

NEW YORK (AP) — NEW YORK (AP) — Syndax Pharmaceuticals Inc. (SNDX) on Monday reported a loss of $84.8 million in its first quarter.

On a per-share basis, the New York-based company said it had a loss of 98 cents.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.04 per share.

The biopharmaceutical company posted revenue of $20 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $14.7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SNDX at https://www.zacks.com/ap/SNDX